GlaxoSmithKline Forms Clinical Imaging Joint Venture With UK’s MRC

Zenopa -- GlaxoSmithKline is allying with the Medical Research Council (MRC) and leading London universities to set up a new joint venture in the field of clinical imaging. The agreement with the MRC, Imperial College London, King's College London and University College London will see the new joint venture take control of operations at GlaxoSmithKline's clinical imaging centre in the capital.
MORE ON THIS TOPIC